EP0889904A2 - Gene codant une proteine se liant a un acide gras du coeur de porc et procede d'identification des caracteristiques du polymorphisme responsables du poids du corps - Google Patents
Gene codant une proteine se liant a un acide gras du coeur de porc et procede d'identification des caracteristiques du polymorphisme responsables du poids du corpsInfo
- Publication number
- EP0889904A2 EP0889904A2 EP97914649A EP97914649A EP0889904A2 EP 0889904 A2 EP0889904 A2 EP 0889904A2 EP 97914649 A EP97914649 A EP 97914649A EP 97914649 A EP97914649 A EP 97914649A EP 0889904 A2 EP0889904 A2 EP 0889904A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- alleles
- pig
- pigs
- fabp
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 44
- 108010062715 Fatty Acid Binding Protein 3 Proteins 0.000 title claims description 43
- 230000037396 body weight Effects 0.000 title description 30
- 102000011026 Fatty Acid Binding Protein 3 Human genes 0.000 title description 26
- 102000054765 polymorphisms of proteins Human genes 0.000 title description 17
- 108700028369 Alleles Proteins 0.000 claims abstract description 36
- 241000282887 Suidae Species 0.000 claims abstract description 25
- 101000911283 Sus scrofa Fatty acid-binding protein, heart Proteins 0.000 claims abstract description 16
- 230000003321 amplification Effects 0.000 claims abstract description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 15
- 238000009395 breeding Methods 0.000 claims abstract description 13
- 230000001488 breeding effect Effects 0.000 claims abstract description 13
- 239000012634 fragment Substances 0.000 claims description 28
- 238000004519 manufacturing process Methods 0.000 claims description 26
- 239000002773 nucleotide Substances 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 2
- 238000003752 polymerase chain reaction Methods 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 abstract description 46
- 239000000463 material Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 20
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 241000282898 Sus scrofa Species 0.000 description 12
- 230000007614 genetic variation Effects 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 238000007918 intramuscular administration Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 101100226596 Gallus gallus FABP gene Proteins 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 235000013372 meat Nutrition 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 108091036066 Three prime untranslated region Proteins 0.000 description 5
- 241000607479 Yersinia pestis Species 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 108091092878 Microsatellite Proteins 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000004754 hybrid cell Anatomy 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 235000020997 lean meat Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 108020005345 3' Untranslated Regions Proteins 0.000 description 3
- 101150058771 FABP gene Proteins 0.000 description 3
- 101710136552 Fatty acid-binding protein, heart Proteins 0.000 description 3
- 102100037738 Fatty acid-binding protein, heart Human genes 0.000 description 3
- 241000283984 Rodentia Species 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000011748 cell maturation Effects 0.000 description 3
- 230000014107 chromosome localization Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 102000000476 Fatty Acid Transport Proteins Human genes 0.000 description 2
- 108010055870 Fatty Acid Transport Proteins Proteins 0.000 description 2
- 101001027663 Homo sapiens Fatty acid-binding protein, heart Proteins 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108700026226 TATA Box Proteins 0.000 description 2
- 108010020713 Tth polymerase Proteins 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 101000653197 Beet necrotic yellow vein virus (isolate Japan/S) Movement protein TGB3 Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101001027658 Bos taurus Fatty acid-binding protein, heart Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 102000030914 Fatty Acid-Binding Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N Maltopentose Chemical compound OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101001027661 Mus musculus Fatty acid-binding protein, heart Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 206010034759 Petit mal epilepsy Diseases 0.000 description 1
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 1
- 241000677647 Proba Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101000911333 Rattus norvegicus Fatty acid-binding protein, heart Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 235000021052 average daily weight gain Nutrition 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 235000021051 daily weight gain Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 108091022862 fatty acid binding Proteins 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000001295 genetical effect Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 102000047025 human FABP3 Human genes 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000021005 inheritance pattern Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000009753 muscle formation Effects 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000009756 muscle regeneration Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
Definitions
- the invention relates to the field of molecular biology as well as to the field of breeding methods for farm animals, in particular pigs.
- the invention relates to the use of diagnostic methods derived from the field of molecular biology to be applied in breeding programmes that select animals on production traits that improve their breeding value.
- breeding programmes By selecting animals on their breeding value calculated mainly from phenotypic measurements of production traits, breeding has greatly improved the genotype for production traits of livestock animals.
- breeding programmes have selected for phenotypic characteristics of animals.
- more recently selection for genotypic characteristics that are associated with improved production traits have gained interest in the field. Selection for phenotypic characteristics entails mainly selection of the offspring or siblings or other relatives of the animals to be selected whereas selection of specific genotypic characteristics allows for earlier and specific detection of animals of interest.
- One of the former methods is a marker assisted selection wherein polymorphisms in markers identified in a random manner are associated with production traits .
- meat production is closely linked to embryonic muscle formation, and, consecutively, to the distribution of muscle cells and fat cells.
- Biologically production is concentrated in defined tissues of the animal, e.g. muscle tissue for lean meat production.
- various levels of selection pressure have been applied to different tissues (i.e. muscle, fat and bone) .
- selecting for lean meat, and thus the abscence of fat one may lose certain traits that are wanted after all, i.e. traits that are associated with taste and thus with the consumers perception of the final product.
- H-FABP heart fatty acid-binding protein
- Fatty acid binding proteins are small intracellular proteins involved in fatty acid transport from the membrane to the sites of ⁇ oxidation and/or triacylglycerol or phospholipid synthesis (Veerkamp and Maatman, 1995). Furthermore, FABP's modulated the intracellular fatty acid concentration (Veerkamp et al.,1993) . Fatty acid metabolism has historically been linked to insuline resistance (Randle, 1963), and therefore mutations in FABP genes may be associated with changes in cellular insulin resistance or dependency, fatty acid oxydation and fatty acid binding.
- FABP's are members of a family of intracellular Iipid binding proteins comprising at least eight structurally distinct types originating from: adipocytes, brain, epidermal cells, heart, intestinal cells, ileal cells, liver and myelin cells.
- H-FABP heart type FABP
- MDGI mammary derived growth inhibitor
- H-FABP can induce cardiac myocyte hypertrophy in vitro, when added to the culture (Burton et al.,1994) and also promotes functional differentiation of mammary epithelial cells in vitro (Yang et al.,1994).
- no secretion of H-FABP has been detected so far.
- H-FABP H-FABP gene specific nucleic acid molucule or pig H-FABP gene specific fragments thereof comprising or hybridising to the nucleotide sequence as shown in figure 1, or its complementary sequence or the RNA equivalents thereof.
- the locus of this gene is on porcine chromosome 6.
- the pig H-FABP gene can be assigned functions in the regulation of intramuscular fat, thereby changing the ratio of fat deposited within the muscle versus fat deposited outside the muscles, i.e. in backfat depots. Since production and deposition of fat is energy consuming and takes away energy for other purposes, such as muscle growth, the regulation of intramuscular fat is correlated to the regulation of growth, and thus body weight and average daily gain and feed efficiency. Also, H-FABP can regulate myocyte (and thus muscle) hypertrophy and thus also muscle regeneration. Since FABP's are involved in fatty acid transport they can influence fatty acid oxidation rates, the metabolism of fatty acid derivatives in the tissue and the fatty acid composition of cells and thus of meat.
- H-FABP may regulate cellular insulin dependency.
- fat storage has an impact on embryo survival, and regulation of H-FABP will influence birth rates and littersize.
- H-FABP regulates functional differentiation of mammary epithelial cells it may be involved in regulating the quantity and composition of the milk available, thus influencing the growth and survival of newborn animals.
- the genetic variation within the pig H-FABP gene with respect to variation in regulation of expression can now be revealed and analysed for association with above production traits and physiological characteristics.
- the present invention further provides a method to generate via recombinant DNA techniques an animal, such as small laboratory animals or farm animals, i.e. a pig, with additional genetic material originating from the pig H-FABP gene. Such animals may than encode wanted alleles of this gene and constitutively or transiently express allelic proteins or fragments thereof that enhance the production or physiological characteristics of those animals.
- the invention further provides methods to generate proteins or (poly)peptides comprising various allelic proteins or fragments thereof derived from the pig H-FABP gene. Such peptides, or antibodies specifically directed against such peptides, may be used to influence production traits in the live animal, but may also be used in cell- culture systems in vitro . Such (poly)peptides or proteins, or antibodies specifically directed against these, may also be used in diagnostic test systems to select animals that express wanted forms of allelic proteins or fragments thereof encoded by the pig H-FABP gene.
- the invention further provides methods localising, identifying or marking genes or alleles or quantitative trait loci, in particular those corresponding to the pig H- FABP gene, in samples, in particular biological samples, cells or tissues, such as but not limited to hair, skin or blood, of farm animals, in particular pigs, by allowing for specific amplification of genomic fragments of those genes or alleles or quantitative trait loci of pigs . Since marker assisted selection of animals is frequentally based upon genetic variation that exists within functional genes that influence a production trait directly, i.e.
- genes such as the pig H-FABP that regulates fatty acid binding one of the methods that the invention provides is a method that identifies or marks loci or genes and that can distinguish between characteristics of alleles of those genes which characteristics serve as markers in selection programmes for animals with specific versions of those genes that are directly linked with improved production traits.
- the invention further provides a method wherein polymorphic restriction sites within functional genes and thus different alleles of those genes are identified by allowing for specific amplification of genomic fragments of those genes, in particular by allowing for specific amplification of fragments of the H-FABP gene.
- Amplification methods are well known in the art, the best known being PCR. A short description of the PCR used herein is given in the experimental part. Other primers, enzymes and conditions can of course be applied.
- a suitable method of identifying wanted alleles is a restriction endonuclease treatment. Suitable restriction enzymes for pig H-FABP alleles are Mspl, Haelll or Hinfl, but others may also be used. By these methods large numbers of pigs can be rapidly genotyped for studies in which genotypic variation can be associated with growth characteristics and other production traits of pigs.
- the methods according to the invention can be developed into diagnostic assays or kits by which selection of pigs with alleles of interest can be performed in routine screening protocols employed in breeding programmes. With such protocols better results of selection can be expected when genes responsible for regulation of commercially interesting body tissues can be rapidly identified and controlled.
- such testing protocols can be used to identify, select and breed farm animals, such as pigs, which have better production traits, such as IMF% or backfat thickness or average daily weight gain or feed efficiency, than the average animal in the population.
- Better production traits such as BW or daily weight gain will increase the production per year expressed as amount of meat per animal raised.
- a population of animals with a higher and less variable IMF% will result in a more homogenous product (meat) which is also better appreciated by putative customers because of a better taste.
- selection for higher IMF% may be possible while at the same time selection against fat deposition in other depots, such as backfat, can be performed.
- the porcine H-FABP gene has been isolated, characterized and chromosomally localized. Poylymorphisms in this gene have been identified. To test the association between bodyweight (BW) and percentage of intramuscular fat (IMF %), animals with different polymorphisms were selected, their bodyweight was measured and the amount of IMF after slaughter was measured.
- BW bodyweight
- IMF intramuscular fat
- a porcine genomic DNA EMBL3/SP6/T7 library (Clontech Laboratories Inc. Palo Alto, CA) was screened using the plaque hybridization method (Sambrook et al. ,1989) .
- plaques were transferred to replica nitrocellulose filters and incubated in denaturation buffer (1.5 M NaCl, 0.5 M NaOH) for 2 minutes, neutralisation buffer (1.5 M NaCl, 0.5 M Tris-HCl pH 8.0) for 5 minutes and fixation buffer (0.2 M Tris-HCl pH 7.5, 2X SSC(0.3 M NaCl, 0.03 M Sodium citrate)) for 30 s.
- denaturation buffer 1.5 M NaCl, 0.5 M NaOH
- neutralisation buffer 1.5 M NaCl, 0.5 M Tris-HCl pH 8.0
- fixation buffer 0.2 M Tris-HCl pH 7.5, 2X SSC(0.3 M NaCl, 0.03 M Sodium citrate
- the filters were prehybridized (6X SSC, 0.5% ( w/v) SDS, 5X Denhardt's and lOOug/ml NaOH treated salmon sperm DNA) for two hours at 67 ⁇ C and hybridized in identical buffer with the addition of the radioactively probe at 67°C overnight.
- the filters were washed four times with 2X SSC, 0.1% ( w/v) SDS for 30 min at room temperature. Twenty plaques that showed positive signals on both replica filters were isolated and each subjected to two additional rounds of low density plaque purification. DNA of these clones was isolated using the plate lysate method (Sambrook et al.,1989).
- PCR amplifications were performed on 1 ⁇ l of a 1:1000 dilution of phage DNA preparations or 50 ngr of genomic DNA in 50 ⁇ l containing 0.2 U Super Tth polymerase (SphaeroQ, Leiden, Nl) in 10 mM Tris-HCl pH 9.0, 50 mM KC1, 1.5 mM MgCI, 0.1% ( w/v) gelatin, 1% Triton X-100, 0.5 ⁇ M of each primer (Pharmacia Biotechnologies, Uppsala, Sweden) and 0.2 ⁇ M of each dNTP (Boehringer Mannheim, Mannheim, Germany) .
- primer sequences as used for the poly-T microsatellite amplification are
- PCR#1 (Table 1) was performed on DNA of all the phage clones to detect porcine H-FABP intron 1 specific fragments. Two of the three phage clones containing the H-FABP gene were used to subclone the various SacI and Kpnl (Boehringer Mannheim, Mannheim, Germany) restriction digestion fragments of the gene region in pBS. Unfortunately, neither of these phage clones contained exon 4 and the 3' untranslated region as detected by restriction analysis. The intron 3/exon 4 splice junction was cloned as PCR#2 (Table 1) product using porcine (Great England) genomic DNA as a template.
- the products of two independent PCR reactions were cloned to identify errors by the Super Tth polymerase upon analysis.
- the 3' untranslated region was isolated using the 5*/3' RACE-PCR kit (Boehringer Mannheim, Mannheim, Germany) with porcine (Meishan) muscle cDNA as the template and porcine H- FABP exon 1 or 3 (Table 1) specific primers in combination with the provided poly-A primer.
- PCR products were cloned in the pT7Blue vector (Novagen Inc. ,Madison, U.S.A.).
- H-FABP (sub)clones were transformed and the recombinant plasmid DNA was isolated and purified with the Wizard Maxiprep kit (Promega, Madison, WI, U.S.A.).
- the nucleotide sequence was determined by dideoxy sequencing, partially by cycle sequencing (Perkin Elmer, ) or autoread sequencing (Pharmacia Biotechnologies, Uppsala, Sweden) and the analysis was performed on a ABI 373 (Applied Biosystems) or ALF DNA sequenator (Pharmacia Biotechnologies, Uppsala, Sweden) respectively.
- Porcine genomic DNA was isolated as described (Sambrook et al.,1989) from EDTA treated blood stored at -80°C. One hundred ng of genomic DNA was used for PCR amplification in 50 ⁇ l reaction as described before. The primer sequences and its corresponding product size and annealing temperature for each combination are given in table 2. Fifteen ⁇ l of the PCR reaction was used for restriction digestion with 2 units of Haelll, Hinfl or Mspl (Boehringer Mannheim) in a total volume of 20 ul . For Haelll and Hinfl the recommended buffer conditions were additionally used whereas Mspl was added directly to the PCR buffer.
- Restriction digestion fragments were loaded on a 2% ( ⁇ fspl) or 3% (Haelll and Hinfl ) agarose (Sigma, St Louis, MO, U.S.A.) gel and after electrophoresis the RFLP patterns were scored by two persons, independently.
- FABP gene to a specific chromosome by PCR.
- Duroc pigs were selected on the basis of the amount of IMF in their slaughtered relatives.
- Performance traits recorded for each pig were live weight at 180 days of age (BW) , backfat thickness (BFT) and for each dam the number of piglets produced alive in first (FPP) or second parity (SPP), respectively.
- meat quality traits i.e. cooking loss, drip loss, intamuscular fat percentage, minolta colour, pH and shear force were measured in a subset of the slaughtered animals.
- H-FABP PCR-RFLP genotyping Blood or hairroots were collected from each animal to isolate genomic DNA for H-FABP PCR-RFLP genotyping.
- the final dataset comprises information from in total 2345 pigs including pedigree.
- H-PABP genotype information is available for at least one of the PCR-RFLPS.
- P(XX), (Xx), (xx) are the estimated chance for each genotype for each animal .
- exon-intron splice junctions were located in comparison with the porcine H-FABP cDNA and the murine H-FABP/MDGI (Treuner et al.,1994) gene sequence.
- a potential TATA-box was located 92 bp upstream the ATG start codon and in the (3'UTR) a consensus poly-A signal sequence was identified (see Fig.l).
- the coding sequences showed 92%, 91%, 87% and 85% identity to the bovine, human, mouse and rat H-FABP sequences at the nucleotide level and the deduced amino acid sequence were 92%, 90%, 87% and 86% identical, respectively (Billich et al. , 1988; Peeters et al. , 1991; Binas et al. , 1992; Claffey et al . , 1987).
- a panel comprising genomic DNA of 7 pig breeds each represented by unrelated animals was used to detect genetic variation in the 5' upstream region, intron 2 and intron 3 of the porcine H-FABP gene. Therefore, part of the 5 ' upstream region was amplified on DNA of this panel using PCR (Table 2) and digested with the restriction enzyme Hinfl . The Hinfl digestion showed two alleles a single fragment of 256 bp (allele h) or two fragments of 197 and 59 bp (allele H) . Similarly intron 3 (PCR#3,Table 1) and intron 2 (Table 2) were tested for genetic variation with the enzymes ⁇ fspl and Haelll respectively, and both showed genetic variation in intron 2.
- Haelll showed one fragment of 850 bp (allele D) and/or fragments of 400 and 450 bp (allele d) . Accurate size determination revealed that these three fragments were 684 bp, 278 bp and 406 bp. Afspl showed a fragment of 850 bp (allele a) and/or fragments of 750 and 50 bp (A) . Accurate size determination revealed that these fragments were 814 bp, 703 bp and 111 bp. Both sites of genetic variation are approximately 300 (285) bp apart.
- Table 3 represents the allele frequencies of the different PCR-RFLPs in the different pig breeds tested.
- the mendelian inheritance pattern of the three PCR- RFLPs was analysed in a porcine family comprising 3 generations of a Great Yorkshire breed. The genotypes of the individual pigs show consistent patterns of inheritance in this family.
- the porcine H-FABP gene was chromosomally localized using a porcine H-FABP gene intron 3 specific PCR which amplified no rodent homologous. Amplification on DNA of two independently established pig/rodent cell hybrid panels and comparison with the cytogenetically (panel A and B) and reference loci data (panel A) revealed a single significant association of the H-FABP gene with chromosome 6 (Table 4) for both cell hybrid panels.
- Table 5 shows the result of mean values and their standard deviations of IMF and bodyweight for different fixed effects which were taken into account in this analyses.
- the PEST program was used to be able to use family information in the analyses of the different fixed effects.
- the used model contained the same fixed effect as the model with SAS but also contains a random animal effect.
- a pedigree file was used containing family relations up to two generations back. Table 7, 10, 11, 12 and 13 show predicted values for the different fixed effects and their standard errors .
- the value tl-l/2 ⁇ is taken from a confidence table and has a value of 1.96 for a 95% confidence interval.
- Table 8 shows the difference between different genotypes of each polymorphism and its 90% and 95% critical values.
- Bodyweight is significantly different for the different genotypes in all three polymorphisms.
- the genotypes of the three polymorphisms tested show a significant (95%) difference in bodyweight (BW) . All three polymorphisms can be used in selection for bodyweight.
- the genotypes of the three polymorphisms show a distinct, albeit non-significant difference in IMF percentage. If there is a difference between different genotypes of 0.20, 50 animals of the least frequent genotype (AADDhh) would be needed to reach a significant (95%) difference of 0.2.
- Tables 9, 10 and 11 show that when more animals are tested, statistically significant differences among the three polymorphisms can indeed be found, for instance for IMF, backfat thickness and BW. Also, tables 12 and 13 show that the effect on IMF, as measured by RFLP testing, can stil be found when the effects are corrected for backfat thickness and/or growth.
- FIG. 1 The porcine H-FABP gene sequence including 1632 bp of the 5 'upstream region and 200 bp of the 3' untranslated region. Exons are represented by bold capital letters and the deduced amino acid sequence is shown directly beneath it. Standard one letter amino acid symbols are used.
- the putative TATA-box, the polyadenylation signal in the 3'UTR and the 13 nucleotide element are underlined. The size of the nondepicted intron sequences is shown between arrowheads.
- the polymorphic Haelll (GGCC), Hinfl (GATTC), Mspl (CAGG) sites and the polymorphic microsatellite sequence (poly-T) are depicted bold and underlined.
- Heart fatty acid binding protein is a novel regulator of cardiac myocyte hypertrophy. Biochem. Biophys. Res. Comm. vol 205 no 3:1822-1828. Chevalet, C. and Corpet, F. (1986) Statistical decision rules concerning synteny or independence between markers . Cytogenet. Cell Genet. 43:132-139.
- Table 1 Primer sequences and the corresponding size and annealing temperatures for PCR reactions of different regions of the porcine H-FABP gene.
- Table 2 The primer sequences and combinations used for PCR- RFLP detection with the corresponding annealing temperature
- PI Pietrain
- WP Wild Pig.
- the second line indicates the nuaber of unrelated animals tested.
- Table 4 Chromosomal localization of the porcine hFABP gene by two independent cell hybrid panels.
- the percentage concordance aa determined by the total o£ equal abaence/preaenc ⁇ in both data aeta divided by 20.
- the ⁇ value r ⁇ preaenta the correlation between both dataaets.
- a gene can be aaa gnad to a chromosome when the concordance s high and the ⁇ ⁇ a more than 0.74 (ayntanic) . Values far ⁇ between 0.59 and 0.74 g ve no validation of the assignment.
- Panel A Rettenberger et a . , 1994a
- Panel B Zijlstra et al., 1994a
- N Number of animals (N) , their mean and standard deviations (std) for intramuscular fat (IMF) and bodyweight (BW) difference from 110 kg at 180 days) for different fixed effects (effect) .
- IMF intramuscular fat
- BW bodyweight
- Table 6 Values of significance for different fixed effects influencing intramuscular fat (IMF) and bodyweight (BW) using a large model (lrg) and using seperate models per fixed effect (ind) (correcting for fixed effects test farm and sexe) .
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention, qui concerne une séquence nouvellement découverte du gène H-FABP du porc, concerne également des procédés d'utilisation du gène considéré et de ses produits. L'invention concerne plus particulièrement des procédés de détection d'allèles différenciés du gène H-FABP du porc, lesquels allèles différenciés sont associés à des différences au niveau des caractéristiques du génotype et/ou du phénotype des porcs possédant ces allèles. L'invention concerne notamment des procédés permettant de faire la distinction entre allèles aboutissant à des phénotypes différents, en l'occurrence, grâce à des techniques d'amplification sélective de matériel génétique dérivé du gène H-FABP du porc. Ces techniques conviennent particulièrement à la sélection d'animaux dans le cadre de programmes de sélection. L'invention concerne enfin des programmes de sélection utilisant de telles techniques.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97914649A EP0889904A2 (fr) | 1996-03-28 | 1997-03-27 | Gene codant une proteine se liant a un acide gras du coeur de porc et procede d'identification des caracteristiques du polymorphisme responsables du poids du corps |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96200855 | 1996-03-28 | ||
| EP96200855 | 1996-03-28 | ||
| EP97914649A EP0889904A2 (fr) | 1996-03-28 | 1997-03-27 | Gene codant une proteine se liant a un acide gras du coeur de porc et procede d'identification des caracteristiques du polymorphisme responsables du poids du corps |
| PCT/NL1997/000157 WO1997035878A2 (fr) | 1996-03-28 | 1997-03-27 | Gene codant une proteine se liant a un acide gras du coeur de porc et procede d'identification des caracteristiques du polymorphisme responsables du poids du corps |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0889904A2 true EP0889904A2 (fr) | 1999-01-13 |
Family
ID=8223829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97914649A Withdrawn EP0889904A2 (fr) | 1996-03-28 | 1997-03-27 | Gene codant une proteine se liant a un acide gras du coeur de porc et procede d'identification des caracteristiques du polymorphisme responsables du poids du corps |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0889904A2 (fr) |
| AU (1) | AU725544B2 (fr) |
| CA (1) | CA2256983A1 (fr) |
| NZ (1) | NZ332072A (fr) |
| WO (1) | WO1997035878A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108103207A (zh) * | 2017-12-28 | 2018-06-01 | 中国农业科学院北京畜牧兽医研究所 | Brca1、jaml及其调控基因在品种选育中的应用 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0929814A1 (fr) * | 1996-10-07 | 1999-07-21 | Meat And Livestock Commission | Methode de selection de fibres musculaires de type duroc |
| GB2333154B (en) * | 1996-10-07 | 2001-05-09 | Meat And Livestock Commission | Assay for duroc muscle fibre tyre |
| EP1015634A1 (fr) * | 1997-09-18 | 2000-07-05 | Pig Genes B.V. I.O. | Gene codant la proteine se liant a l'acide gras des adipocytes du porc, et procedes de localisation, d'identification ou marquage des genes ou alleles ou loci de caractere quantitatif des animaux de ferme |
| GB9929140D0 (en) | 1999-12-10 | 2000-02-02 | Univ Geneve | Diagnostic assay for stroke |
| WO2002020850A2 (fr) | 2000-09-08 | 2002-03-14 | Iowa State Universtiy Research Foundation, Inc. | Nouveaux alleles de prkag3 et utilisation de ceux-ci comme marqueurs genetiques de caracteristiques de reproduction et de qualite de viande |
| CN101935706B (zh) * | 2010-09-02 | 2012-05-30 | 中国农业科学院北京畜牧兽医研究所 | 一种检测猪肉品质性状的方法及专用引物对 |
| CN113913536B (zh) * | 2021-11-30 | 2022-08-16 | 湖北省农业科学院畜牧兽医研究所 | 猪eepd1基因第一外显子变异作为肌内脂肪含量性状的遗传标记及应用 |
| CN118243213B (zh) * | 2024-03-25 | 2024-09-03 | 青岛零一动测数据科技有限公司 | 一种振动噪声监测分析方法及振动噪声监测系统 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0580767B1 (fr) * | 1991-04-19 | 2000-12-27 | Iowa State University Research Foundation, Inc. | Marqueurs genetiques de la taille de portees de porcs |
| DE4338817A1 (de) * | 1993-11-13 | 1995-06-14 | Max Delbrueck Centrum | Gensequenzen von Cellular X Binding Proteinen |
-
1997
- 1997-03-27 EP EP97914649A patent/EP0889904A2/fr not_active Withdrawn
- 1997-03-27 CA CA002256983A patent/CA2256983A1/fr not_active Abandoned
- 1997-03-27 NZ NZ332072A patent/NZ332072A/xx unknown
- 1997-03-27 AU AU21803/97A patent/AU725544B2/en not_active Ceased
- 1997-03-27 WO PCT/NL1997/000157 patent/WO1997035878A2/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9735878A2 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108103207A (zh) * | 2017-12-28 | 2018-06-01 | 中国农业科学院北京畜牧兽医研究所 | Brca1、jaml及其调控基因在品种选育中的应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2180397A (en) | 1997-10-17 |
| AU725544B2 (en) | 2000-10-12 |
| NZ332072A (en) | 1999-11-29 |
| WO1997035878A3 (fr) | 1997-10-30 |
| CA2256983A1 (fr) | 1997-10-02 |
| WO1997035878A2 (fr) | 1997-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gerbens et al. | The adipocyte fatty acid-binding protein locus: characterization and association with intramuscular fat content in pigs | |
| Te Pas et al. | Genetic variation at the porcine MYF-5 gene locus. Lack of association with meat production traits | |
| Ciobanu et al. | Genetic variation in two conserved local Romanian pig breeds using type 1 DNA markers | |
| CA2261157C (fr) | Polymorphisme du gene pit-1 et detection de caracteres chez des animaux | |
| AU725544B2 (en) | The porcine heart fatty acid-binding protein encoding gene and methods to identify polymorphisms associated with body weight | |
| CN116590433B (zh) | 大白母猪繁殖性能的分子标记、引物、试剂盒、鉴定方法及应用 | |
| NZ541698A (en) | Selecting animals for desired genotypic or potential phenotypic properties based on a single nucleotide polymorphism (snp) in intron 3 of the IGF2 gene | |
| US6143880A (en) | Pig myogenin gene and method to identify polymorphisms related to muscle growth | |
| WO2006101623A2 (fr) | Marqueurs cstf1 et c20orf43 de la qualite de la viande et de la vitesse de croissance des animaux | |
| EP1195382B1 (fr) | Gène specifique des testicules | |
| EP1598430B1 (fr) | Procédé destiné a évaluer le goût et la texture de la viande de boeuf au moyen d'un haplotype de la gène desaturase stearoyl-CoA | |
| KR100804310B1 (ko) | 소 근내지방도 관련 fabp4 유전자를 이용한 dna마커 | |
| Liang et al. | Investigation of the association of two candidate genes (H-FABP and PSMC1) with growth and carcass traits in Qinchuan beef cattle from China | |
| MORAVČÍKOVÁ et al. | Associations between polymorphisms in the leptin gene and milk production traits in Pinzgau and Slovak Spotted cattle | |
| CA2304349A1 (fr) | Gene codant la proteine se liant a l'acide gras des adipocytes du porc, et procedes de localisation, d'identification ou marquage des genes ou alleles ou loci de caractere quantitatif des animaux de ferme | |
| US7157231B2 (en) | Method of evaluating useful cattle | |
| MXPA98007876A (es) | Gen que codifica la proteina de enlace a acidosgrasos de corazon de porcino y metodos para identificar polimorfismos asociados con el peso corporal | |
| Wu et al. | Identification of four SNPs and association analysis with meat quality traits in the porcine Pitx2c gene | |
| WO2007068936A2 (fr) | Méthode de diagnostic | |
| EP1485506B1 (fr) | Procede d'identification des qualites de la production laitiere des animaux par analyse du polymorphisme des genes pit-1 et de kappa caseine | |
| KR101796160B1 (ko) | 돼지의 산자수 예측용 dact3 유전자의 snp 마커 및 이를 이용한 돼지 다산 개체 선발 방법 | |
| CN117947176A (zh) | 一种评估中国西门塔尔牛的牛肉品质性状的方法 | |
| Wu et al. | Identification of four SNPs in the porcine Pitx2c gene and association with meat quality traits | |
| Hansen | Evaluating six positional candidate genes for effects on meat tenderness | |
| CN116769923A (zh) | 一种鸡生长发育相关InDel多态性标记、引物、试剂盒及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19981005 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL PAYMENT 981005;LT PAYMENT 981005;LV PAYMENT 981005;RO PAYMENT 981005;SI PAYMENT 981005 |
|
| 17Q | First examination report despatched |
Effective date: 20020111 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20020526 |